조대원

조대원 discloses dealings in 피플바이오 to DART (FSS). We count 7 filings; the first trade dates from 13 July 2021 and the latest from 20 October 2023.

Both buying and selling appear: 4 purchases worth €1.6M, against 1 sale worth €77k. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 3 purchases and 1 sale.

In size, the median ticket on the buying side is €295k. On 2 out of 4 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 27 October 2023 came the latest disclosure, a transaction in 피플바이오. The last purchase on record was published on 22 September 2023, which is 1,145 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.